World Health Organization. Strategic Advisory Group on In Vitro Diagnostics. Meeting
Published: 2018
Total Pages: 34
Get eBook
"Access to good quality, affordable, and appropriate health products is indispensable to advance universal health coverage,address health emergencies,and promote healthier populations–the three strategic priorities of the World Health Organization (WHO)Thirteenth General Programme of Work 2019–2023.1Without access to In vitrodiagnostics (IVDs),health providers cannot diagnose patients effectively and promptly or provide appropriate treatments.In March 2017, the WHO Expert Committee on Selection and Use of Essential Medicines recommended the development of a Model List of Essential In Vitro Diagnostics (EDL), to complement the WHO Model List of Essential Medicines (EML). To support the EDL and to advise on other in vitro diagnostic initiatives, WHO created a Strategic Advisory Group of Experts on In VitroDiagnostics (SAGE-IVD). The SAGE-IVD, which includes 19 multidisciplinary members with global representation, held its first meeting from 16–20April 2018 at WHO headquarters, Geneva. The SAGE IVD made recommendations for the content, format and implementation of the first edition of the EDL.It is foreseen that EDL will be an important tool in increasing access to appropriate, affordable and quality-assured IVDs, particularly where they are most needed to address health priorities"--Executive summary.